Nobuhiko Yamashita

Title: Nobuhiko Yamashita: Innovator in Monoclonal Antibodies

Introduction

Nobuhiko Yamashita is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. With a total of 5 patents, his work has advanced the monitoring and analysis of polycyclic aromatic hydrocarbons (PAHs) and human calcitonin.

Latest Patents

Yamashita's latest patents include innovative solutions such as anti-PAH monoclonal antibodies and cell lines producing the same. This invention provides monoclonal antibodies suitable for monitoring PAHs through an immunoassay, along with hybridoma cell lines that produce these antibodies. Additionally, it offers PAH conjugates that serve as immunogens for antibody preparation and as standard substances in competitive assays. Another notable patent involves anti-human calcitonin monoclonal antibodies, which exhibit a high affinity for human calcitonin. This patent also includes a sandwich immunoassay utilizing these antibodies for determining human calcitonin levels in blood.

Career Highlights

Nobuhiko Yamashita is associated with Osaka Gas Company Limited, where he has been instrumental in research and development. His expertise in monoclonal antibodies has positioned him as a key figure in the field, contributing to advancements that have practical applications in health and environmental monitoring.

Collaborations

Yamashita has collaborated with notable colleagues such as Chiwa Kataoka and Kazunobu Miura. These partnerships have fostered innovation and have been essential in the development of his patented technologies.

Conclusion

Nobuhiko Yamashita's work in the field of monoclonal antibodies has led to significant advancements in immunoassays and environmental monitoring. His contributions continue to impact both scientific research and practical applications in healthcare.